Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Douglas Smith

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Molecular Diagnostics : JMD|June 6, 2009
A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practiceNatini Jinawath, Alexis Norris-Kirby, B Douglas Smith, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 13, 2002
The role of growth factors in the activity of pharmacological differentiation agentsWilliam H Matsui, Douglas E Gladstone, Milada S Vala, et al.
The Journal of Molecular Diagnostics : JMD|April 23, 2003
Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assayKathleen M Murphy, Mark Levis, Michael J Hafez, et al.
Leukemia Research|October 29, 2024
The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysisSusanne Isfort, Carlo Gambacorti-Passerini, Tim H Brümmendorf, et al.
Blood|March 31, 2005
Internal tandem duplications of the FLT3 gene are present in leukemia stem cellsMark Levis, Kathleen M Murphy, Rosalyn Pham, et al.
Blood|January 17, 2004
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemiaB Douglas Smith, Mark Levis, Miloslav Beran, et al.
Stem Cells Translational Medicine|March 16, 2017
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex VivoKatherine L B Knorr, Laura E Finn, B Douglas Smith, et al.
JCO Oncology Practice|February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot StudyMirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Leukemia & Lymphoma|April 5, 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsTara M Robinson, Gabrielle T Prince, Chris Thoburn, et al.
Blood|November 25, 2003
Characterization of clonogenic multiple myeloma cellsWilliam Matsui, Carol Ann Huff, Qiuju Wang, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Molecular Diagnostics : JMD|June 6, 2009
A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practiceNatini Jinawath, Alexis Norris-Kirby, B Douglas Smith, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 13, 2002
The role of growth factors in the activity of pharmacological differentiation agentsWilliam H Matsui, Douglas E Gladstone, Milada S Vala, et al.
The Journal of Molecular Diagnostics : JMD|April 23, 2003
Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assayKathleen M Murphy, Mark Levis, Michael J Hafez, et al.
Leukemia Research|October 29, 2024
The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysisSusanne Isfort, Carlo Gambacorti-Passerini, Tim H Brümmendorf, et al.
Blood|March 31, 2005
Internal tandem duplications of the FLT3 gene are present in leukemia stem cellsMark Levis, Kathleen M Murphy, Rosalyn Pham, et al.
Blood|January 17, 2004
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemiaB Douglas Smith, Mark Levis, Miloslav Beran, et al.
Stem Cells Translational Medicine|March 16, 2017
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex VivoKatherine L B Knorr, Laura E Finn, B Douglas Smith, et al.
JCO Oncology Practice|February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot StudyMirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Leukemia & Lymphoma|April 5, 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsTara M Robinson, Gabrielle T Prince, Chris Thoburn, et al.
Blood|November 25, 2003
Characterization of clonogenic multiple myeloma cellsWilliam Matsui, Carol Ann Huff, Qiuju Wang, et al.
Pageof 21